Bank Pictet & Cie (Europe)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.64M | Buy |
20,906
+15,004
| +254% | +$1.17M | 0.04% | 106 |
|
|
2025
Q1 | $428K | Sell |
5,902
-4,329
| -42% | -$314K | 0.01% | 141 |
|
|
2024
Q4 | $757K | Buy |
10,231
+1,463
| +17% | +$108K | 0.02% | 120 |
|
|
2024
Q3 | $579K | Buy |
8,768
+4,068
| +87% | +$268K | 0.01% | 118 |
|
|
2024
Q2 | $434K | Hold |
4,700
| – | – | 0.01% | 124 |
|
|
2024
Q1 | $449K | Hold |
4,700
| – | – | 0.01% | 136 |
|
|
2023
Q4 | $358K | Hold |
4,700
| – | – | 0.01% | 214 |
|
|
2023
Q3 | $326K | Hold |
4,700
| – | – | 0.01% | 210 |
|
|
2023
Q2 | $443K | Sell |
4,700
-3,494
| -43% | -$330K | 0.02% | 187 |
|
|
2023
Q1 | $678K | Hold |
8,194
| – | – | 0.03% | 122 |
|
|
2022
Q4 | $611K | Sell |
8,194
-1,741
| -18% | -$130K | 0.03% | 115 |
|
|
2022
Q3 | $821K | Sell |
9,935
-246
| -2% | -$20.3K | 0.04% | 106 |
|
|
2022
Q2 | $968K | Sell |
10,181
-1,387
| -12% | -$132K | 0.04% | 99 |
|
|
2022
Q1 | $1.36M | Buy |
11,568
+636
| +6% | +$74.9K | 0.05% | 96 |
|
|
2021
Q4 | $1.42M | Buy |
10,932
+710
| +7% | +$92K | 0.05% | 99 |
|
|
2021
Q3 | $1.16M | Sell |
10,222
-2,746
| -21% | -$311K | 0.04% | 100 |
|
|
2021
Q2 | $1.34M | Buy |
12,968
+1,061
| +9% | +$110K | 0.05% | 99 |
|
|
2021
Q1 | $996K | Buy |
+11,907
| New | +$996K | 0.04% | 104 |
|